IMMUNIC, INC.
Profile
Company Names
IMMUNIC, INC.
VITAL THERAPIES INC
Addresses
1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, X1 10036
1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, X1 10036
1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, NY 10036
15010 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO, CA 92128
15222 AVENUE OF SCIENCE, SUITE B, SAN DIEGO, CA 92128
Phone Numbers
(332) 255-9818
858-673-6840
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$514,351,307.00
Number of Funding Rounds:
10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2026-02-17
$200,000,000.00
$200,000,000.00
$0.00
Equity
9
2024-01-04
$80,000,016.00
$240,000,000.00
$159,999,984.00
Equity
8
2022-10-10
$60,000,002.00
$60,000,002.00
$0.00
Equity
7
2014-01-24
$13,928,129.00
$13,928,129.00
$0.00
Equity
6
2013-02-28
$31,979,470.00
$31,979,470.00
$0.00
Equity
5
2012-09-25
$86,145,589.00
$86,145,589.00
$0.00
Equity
4
2012-05-14
$2,500,000.00
INDEFINITE
INDEFINITE
Debt
3
2012-02-03
$929,831.00
$1,500,000.00
$570,169.00
Equity
2
2011-05-19
$22,617,179.00
$56,860,223.00
$34,243,044.00
Equity
1
2009-09-25
$16,251,091.00
$16,251,091.00
$0.00
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT
ASHLEY
EXECUTIVE OFFICER
DOUGLAS
GODSHALL
DIRECTOR
ROSS
A.
JAFFE
DIRECTOR
CHARLES
LIAMOS
DIRECTOR
DUANE
NASH
EXECUTIVE OFFICER, DIRECTOR
MUNEER
SATTER
DIRECTOR
LOWELL
E.
SEARS
DIRECTOR
PATRICK
WALSH
EXECUTIVE OFFICER
AAI HOLDINGS CORP.
| PWK PARTNERS QP, L.P.
| PWK PARTNERS ATLAS FUND I, L.P.
| PW PARTNERS MASTER FUND, L.P.
| PW PARTNERS ATLAS FUND LP
| PW PARTNERS ATLAS FUND II, LP
| AIRSIGN, INC.
| PW PARTNERS ATLAS FUND III, LP
| PW ACQUISITIONS LP
| CLASSY, INC.
| PW PARTNERS MASTER FUND (QP), L.P.
| INCONTEXT SOLUTIONS, INC.
| IRONCORE LABS, INC.
| EAGLEHAWK ONE, INC.
| WEST LOT HOLDINGS, LLC
| ENVISION DIAGNOSTICS, INC.
| CLASSY HOLDINGS, INC.
| COPPER LABS, INC
| IMMUNIC, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-02-17
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-01-24
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-01-24
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2013-02-28
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
